ghk-cu tolerance downregulation desensitization receptor or or loss of effectiveness or Evaluating the stability and safety of GHK-Cu encapsulated in an ghk-cu peptide tolerance desensitization receptor

Product Specifications Volume10mL FormatGlass Vial CategoryResearch Supply Intended UseResearch & Laboratory Pack Options1 vial / 10-vial pack Shipping Information Standard Domestic 25 business days Express Shipping 12 business days (available at checkout) Free Shipping On orders over $250 Frequently Asked Questions Before You Order Common Questions For research and laboratory use only

Pre-Blend Weekly Schedule Example Pre-blend dose at each titration step Phase Start Weeks 1-4 Draw Volume 0.40 mL (40 units) Reta Delivered 2.0 mg Cag Delivered 0.4 mg Phase Step 1 Weeks 5-8 Draw Volume 0.60 mL (60 units) Reta Delivered 3.0 mg Cag Delivered 0.6 mg Phase Step 2 Weeks 9-16 Draw Volume 0.80 mL (80 units) Reta Delivered 4.0 mg Cag Delivered 0.8 mg Phase Step 3 Weeks 17-20 Draw Volume 1.20 mL (120 units) Reta Delivered 6.0 mg Cag Delivered 1.2 mg Phase Step 4 Weeks 21-24 Draw Volume 1.60 mL (160 units) Reta Delivered 8.0 mg Cag Delivered 1.6 mg Phase Maintenance Weeks 25+ Draw Volume 2.40 mL (240 units) Reta Delivered 12.0 mg Cag Delivered 2.4 mg One injection per week

However, they can be significantly improved with appropriate strategies, environmental modifications, and sometimes medication

Documented best practice for sealed vials: A cool, dry location at room temperature, protected from direct light, in the original manufacturer carton if possible